Cytokeratin-positive cells in bone marrow in comparison with other prognostic factors in colon carcinoma

Langenbeck's Archives of Surgery

Volumn 385, Issue 5, 2000, Pages 337-343

  Leinung, S ^a   Wur P ^a   Weiss, C L ^b   Roder I ^b   Schonfelder M ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Chirurgische Abteilung   (Germany)

Author keywords

Bone marrow; Colon carcinoma; Isolated disseminated tumor cells

Indexed keywords

CYTOKERATIN;

ADULT; AGED; ARTICLE; BONE MARROW METASTASIS; CANCER RECURRENCE; CELL SELECTION; COLON CARCINOMA; HUMAN; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT INDICATION;

EID: 0033856438     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004230000147     Document Type: Article

References (29)

1. Broil R, Lembcke K, Stock C, Zingler M, Duchrow M, Schimmelpennig H, Strik M, Müller G, Kujat P, Bruch H-P (1996) Tumorzelldissemination in das Knochenmark und in die Peritonealhöhle - Eine immunzytochemische Untersuchung an Patienten mit einem Magen- oder kolorektalen Karzinom. Langenbecks Arch Chir 381:51-58
2. Broll R, Schauer V, Schimmelpennig H, Strik M, Weltmann A Best R, Bruch HP, Duchrow M (1997) Prognostic relevance of occult tumor cells in lymph nodes of colorectal carcinomas - an immuno-histochemical study. Dis Colon Rectum 40:1465-1471
3. Cox DR (1972) Regression models and life tables. J R Statist Soc 834:187-220
4. Funke I, Schlimok G, Bock B, Schweiberer B, Riethmiiller G (1989) Micrometastasis: characterization and tumorgenicity of disseminated tumor cells in human bone marrow. In: Osborn M, Weber K (eds) Cytoskeletal proteins in tumor diagnosis. Cold Spring Harbor Laboratory, Cold Spring Harbor, pp 241-244
5. Funke I, Schraut W (1998) Meta-analyses of studies on bone marrow micrometastases: an independent prognostic impact remains to be substantiated. J Clin Oncol 16: 557-566
6. Juhl H, Kalthoff H, Krüger U, Henné-Bruns D, Kremer B (1995) Immunozytologischer Nachweis mikrometastatischer Zellen bei Patienten mit gastrointestinalen Tumoren. Zentralbl Chir 120:116-122
7. Juhl H, Stritzel M, Wroblewski A, Henné-Bruns D, Kremer B, Schmiegel WH, Neumaier M, Wagener C, Schreiber HW, Kalthoff H (1994) Immunocytological detection of micrometastatic cells: comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients. Int J Cancer 57:3030-3035
8. Leinung S, Schönfelder A, Schönfelder M (1998) Cytokeratinpositive Zellen im Knochenmark bei Patienten mit gastralen und colorectalen Carcinomen: Korrelation mit konventionellen Prognosekriterien und dem klinischen Verlauf. Zentralbl Chir 123:520-524
9. Leinung S, Petzold A, Weiss C-L, Braukhoff M, Schönfelder M, Steuber J, Taha HMM, Esele E (1998) The biological significance of free tumor cells in a comparative study of gastric, colorectal and breast cancer using a CK II and a 17-1-A antibody. J Cancer Res Clin Oncol (Suppl) 124:142
10. Leinung S, Schönfelder A, Schönfelder M ( 1996) Experience in the immunocytochemical detection of micrometastatic tumor cells in human bone marrow of gastric and colorectal cancer patients. J Hematother 5: 574
11. Moll R, Franke WW, Schiller DL, Geiger B, Krepier R (1982) The catalogue of human cytokeratins pattern of expression in normal epithelia, tumors and cultured cells. Cell 31:11-24
12. Oruzio D, Hempel D, Schlimok G ( 1997) "Knochenmarksmikrometastasen" epithelialer Tumoren-Nachweis und klinische Bedeutung. Onkologe 3:66-72
13. Pantel K, von Knebel Doeberitz M, Izbicki JR, Riethmüller G (1997) Disseminierte Tumorzellen: Diagnostik, prognostische Relevanz, Phänotypisierung und therapeutische Strategien. Chirurg 68:1241-1250
14. Pantel K, Riethmüller G (1994) Detection, characterization and antibody therapy of minimal residual epithelial cancer. Oncology 11:4-9
15. Pantel K, Riethmüller G (1996) Micrometastasis detection and treatment with antibodies. Curr Top Microbiol Immunol213(III):l-18
16. Pantel K, Schlimok G, Angstwurm M, Weckermann D, Schmaus W, Gath H, Passlick B, Izbicki JR, Riethmüller G (1995) Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J Hematother 3:165-173
17. Riethmüller G, Johnson J (1992) Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancer. Curr Opin Immunol 4:647-655
18. Riethmüller G, Holz E, Schlimok G, Schmiegel W, Raab R, Höffken K, Gruber R, Funke l, Pichlmaier H, Hirche H, Buggisch P, Witte J, Pichlmayr R (1998) Monoclonal antibody therapy for resected Dukes's C colorectal cancer: seven-year outcome of a multicenter randomized trial. J ClinOncol 16:1788-1794
19. Riethmüller G, Schneider-Gädicke, Schlimok G, Schmiegel W, Raab R, Höffken K, Gruber R, Pichelmaier H, Hirche H, Pichelmayr R, Buggisch P, Witte J, the German Cancer Aid 17-1A Study Group (1994) Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. The Lancet 343:1177-1183
20. Schirren J (1995) Kommentar auf Anforderung der Schriftleitung. Chirurg 8:785-786
21. Schlimok G, Funke I, Bock B, Schwererer B, Witte J, Riethmüller G (1990) Epithelial tumor cells in bone marrow of patients with colorectal cancer: immunocytochemical detection, phenotypic characterization and prognostic significance. J Clin Oncol 8:831-837
22. Schlimok G, Funke I, Holzmann B, Göttlinger G, Schmidt G, Häuser H, Swierkot S, Warnecke HH, Schneider B, Koprowski H, Riethmüller G (1987) Micrometastatic cancer cells in bone marrow: in vitro detection with anticytokeratin and in vivo labeling with and-17-1A monoclonal antibodies. Proc Natl Acad Sei USA 84:8672-8676
23. Schlimok G, Riethmüller G (1995) Monoclonal antibodies in the therapy of minimally residual solid tumors. Onkologie 18:403
24. Soeth E, Röder C, Juhl H, Kruger U, Kremer B, Kalthoff H (1996) The detection of disseminated tumor cells in bone marrow from colorectal-cancer patients by a cytokeratin-20-specific nested reverse transcriptase-polymerase chain reaction is related to the stage of disease. Int J Cancer 69:278-282
25. Soeth E, Vogler I, Rôder C, Juhl H, Marxsen J, Kruger U, Henné-Bruns D, Kremer B, Kalthoff H (1997) Comparative analysis of bone marrow and venous blood isolated from gastrointestinal cancer patients for the disseminated tumor cells using reverse transcription PCR. Cancer Res 57:3106-3110
26. UICC (1993) TNM Klassifikation maligner Tumoren, 3rd edn. Springer, Berlin Heidelberg New York
27. UICC (1998) TNM Klassifikation maligner Tumoren, 4th edn. In: Hermanek P, Wagner G, Wittekind C (eds) Springer, Berlin Heidelberg New York
28. von Knebel Doeberitz M, Gebert J, Herfarth Ch (1996) Der Einflu molekularer Diagnostikverfahren auf die chirurgische Therapie chirurgischer Erkrankungen. Chirurg 67:967
29. Zippelius A, Kufer P, Honold G (1997) Limitations of reverse transcriptasepolymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. J Clin Oncol 15:2701